GlassScriptPhysician profile
Ada D Stewart
NPI 1750333050
$186,409.58
in general payments reported to CMS, 2019-2025
28 companies · $64K in 2025
The $64K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,326 · 2020: $553 · 2021: $1,104 · 2022: $579 · 2023: $34K · 2024: $85K · 2025: $64K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $74K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $72K · Travel and Lodging: $28K · Food and Beverage: $9,165 · Entertainment: $13.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $73,625.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $72,076.00 |
| Travel and Lodging | $27,967.77 |
| Food and Beverage | $9,165.45 |
| Entertainment | $13.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $77,854.47 | 2019-2025 | Epclusa, Biktarvy, Descovy |
| Gen-Probe, INC. | $72,980.47 | 2023-2025 | Aptima |
| Viiv Healthcare Company | $23,401.05 | 2019-2025 | Apretude, Dovato, Cabenuva |
| Hologic Sales and Service, LLC | $8,890.54 | 2022-2025 | Aptima, Fetal Fibronectin Enzyme Immunoassay, Btx |
| Astrazeneca Pharmaceuticals LP | $452.17 | 2019-2024 | Farxiga, Airsupra |
| Lilly USA, LLC | $367.80 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Abbvie INC. | $353.33 | 2019-2025 | |
| Novo Nordisk INC | $345.04 | 2021-2025 | Wegovy, Saxenda |
| Janssen Products, LP | $298.90 | 2020-2021 | |
| Abbott Laboratories | $293.69 | 2021-2025 | Freestyle Libre 3 |
| Eko Health, INC. | $200.00 | 2024 | |
| Merck Sharp & Dohme LLC | $177.40 | 2019-2025 | Delstrigo, Pifeltro |
| Pfizer INC. | $170.47 | 2021-2025 | |
| Janssen Biotech, INC. | $102.23 | 2019-2022 | |
| Theratechnologies INC. | $96.51 | 2019-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $79.70 | 2023 | Interstim |
| Teleflex LLC | $71.31 | 2023 | Urolift |
| Dexcom, INC. | $46.28 | 2020-2024 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $46.21 | 2023-2025 | Cologuard Collection Kit |
| Ultragenyx Pharmaceutical INC. | $35.71 | 2022 | |
| Napo Pharmaceuticals INC | $26.32 | 2019 | |
| Astellas Pharma US INC | $24.83 | 2025 | Veozah |
| Stryker Corporation | $17.24 | 2025 | Clottriever Bold Catheter |
| Novartis Pharmaceuticals Corporation | $17.23 | 2019 | |
| Alexion Pharmaceuticals, INC. | $16.70 | 2025 | Strensiq |
| Janssen Pharmaceuticals, INC | $16.37 | 2021 | |
| Evofem Biosciences, INC. | $13.95 | 2021 | |
| Optos, INC. | $13.66 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ada Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.